A new weight loss injection is coming to Israel

U.S. pharma company Eli Lilly announced it will begin marketing the Mounjaro (Tirzepatide) injection in Israel to treat obesity and type 2 diabetes starting September 15. The drug has been submitted for both indications to the upcoming health…